According to the Chicago Sun-Times, a new cancer care facility is in the works for University of Chicago Medicine. This hospital features one of the top mesothelioma cancer centers in the United States.

The report states the new hospital will cost $633 million and be at the campus in Hyde Park, a subdivision in the south side of Chicago. This facility will focus on cancer treatment, streamlining care for patients with all types of malignancies. Construction is estimated to begin in 2023 – if the cancer center addition is approved – and open to patients in 2026.

University of Chicago Medicine has a comprehensive cancer center, but space is an issue. University of Chicago Medical Center, the main hospital, is almost always close to patient capacity for cancer care and non-cancer treatment.

“In fact, the COVID pandemic really revealed that to us more than anything else, that we need more capacity to be able to care for our cancer and non-cancer patients,” said Dr. Kunle Odunsi, the cancer center’s director.


More Information About University of Chicago Medicine

University of Chicago Medicine features multiple mesothelioma specialists on staff. Dr. Kiran Turaga is a gastrointestinal cancer doctor who performs HIPEC cytoreductive surgery for abdominal malignancies, including peritoneal mesothelioma. Dr. Hedy Lee Kindler is the director of University of Chicago Medicine’s mesothelioma treatment division.

Dr. Jessica Donnington, a thoracic surgeon, and medical oncologist Dr. Mark Ferguson are others in the mesothelioma treatment team.

University of Chicago Health is one of the top HIPEC programs in the midwest region of the United States. Dr. Kiran Turaga, a gastrointestinal doctor who does peritoneal mesothelioma surgery, says the biggest challenge is it’s a disease of the lining.


Details of New Addition to Hospital System

The new building would be seven stories tall, feature 128 beds and 100 examination rooms. Other features are rooms for genetic testing, imaging, infusion, counseling and urgent care. University of Chicago Medicine anticipates the new cancer center add-on to increase the outpatient and inpatient volume, allowing doctors to provide care for more patients – and more frequently.

According to the report, the cancer center will focus on early detection of aggressive and hard-to-treat tumors, particularly those affecting residents of Chicago’s south side, which has a large population of minorities. Mesothelioma is one of the most aggressive and toughest-to-treat cancers, which is why early detection is essential for long survival.

Minorities are also affected by discrepancies in quality care for mesothelioma, leading to lower survival rates, according to scientific studies examining the differences in mesothelioma diagnosis and treatment across ethnicities. Mesothelioma Guide also reported recently that minorities are also underrepresented in cancer clinical trials, including mesothelioma studies, and a cancer center in the community would improve access to these potentially life-saving tests of new cancer therapies.

Mesothelioma patients interested in University of Chicago Medicine should contact our lead patient advocate, Nurse Karen Ritter. Email for tips on communicating with the hospital for initial consultations.

    Sources & Author

Devin Goldan image

About the Writer, Devin Golden

Devin Golden is the content writer for Mesothelioma Guide. He produces mesothelioma-related content on various mediums, including the Mesothelioma Guide website and social media channels. Devin's objective is to translate complex information regarding mesothelioma into informative, easily absorbable content to help patients and their loved ones.

Guide Packet Desktop Ad

Want to learn more?

Try Our Free Guide to Fighting Mesothelioma

Get in depth knowledge about your diagnosis & the best treatments.

Learn More
Guide Packet Mobile Ad